Q2 2025 · 13F-HR
TANG CAPITAL MANAGEMENT LLCholdings as filed
Filed 2025-08-14 · accession 0001214659-25-012272
$1.98B
Reported value
200
Positions
2025-06-30
Period end
The Brief · TANG CAPITAL MANAGEMENT LLC · Q2 2025
AI · grounded in 13F
TANG CAPITAL MANAGEMENT LLC established a new position in GALAPAGOS NV LKFT valued at $111.7M. The fund also initiated new stakes in TARSUS PHARMACEUTICALS INC TARS for $99.4M and AURINIA PHARMACEUTICALS INC AUPH for $84.9M. Other new additions include IMMUNOCORE HLDGS PLC IMCR and KINIKSA PHARMACEUTICALS INTL KNSA. The fund manages a total of 200 positions with $1.98B in assets under management.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 36315X101 | LKFT | GALAPAGOS NV | $111.7M | 5.65% | 3,990,111 | Common | SHARED |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $99.4M | 5.03% | 2,454,797 | Common | SHARED |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $84.9M | 4.29% | 10,029,500 | Common | SHARED |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $66.1M | 3.34% | 2,105,608 | Common | SHARED |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $64.4M | 3.26% | 2,328,609 | Common | SHARED |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $62.9M | 3.18% | 1,236,027 | Common | SHARED |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $55.9M | 2.82% | 4,941,798 | Common | SHARED |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $53.7M | 2.72% | 1,100,000 | Common | SHARED |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $47.9M | 2.42% | 3,200,000 | Common | SHARED |
| 30052C107 | EOLS | EVOLUS INC | $46.0M | 2.33% | 4,997,399 | Common | SHARED |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $39.7M | 2.01% | 2,842,925 | Common | SHARED |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $38.2M | 1.93% | 3,826,692 | Common | SHARED |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $35.1M | 1.77% | 13,496,208 | Common | SHARED |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $32.4M | 1.64% | 1,500,000 | Common | SHARED |
| 92337R101 | VERA | VERA THERAPEUTICS INC CL A | $31.8M | 1.61% | 1,350,000 | Common | SHARED |
| N5749R100 | 2GH | MERUS N V | $31.6M | 1.60% | 600,000 | Common | SHARED |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $29.7M | 1.50% | 3,200,000 | Common | SHARED |
| 032724106 | ANAB | ANAPTYSBIO INC | $29.5M | 1.49% | 1,330,879 | Common | SHARED |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $29.5M | 1.49% | 830,000 | Common | SHARED |
| 09075V102 | BNTX | BIONTECH SE | $28.7M | 1.45% | 270,000 | Common | SHARED |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $27.9M | 1.41% | 8,068,058 | Common | SHARED |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $26.3M | 1.33% | 897,616 | Common | SHARED |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $25.1M | 1.27% | 11,065,662 | Common | SHARED |
| 592688105 | MTD | METTLER-TOLEDO INTERNATIONAL | $22.9M | 1.16% | 19,500 | Common | SHARED |
| 097023105 | BA | BOEING CO | $22.1M | 1.12% | 105,662 | Common | SHARED |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $20.7M | 1.05% | 317,500 | Common | SHARED |
| 67066G104 | NVDA | NVIDIA CORPORATION | $20.6M | 1.04% | 130,509 | Common | SHARED |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $20.2M | 1.02% | 190,000 | Common | SHARED |
| 457669307 | INSM | INSMED INC | $20.1M | 1.02% | 200,000 | Common | SHARED |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $19.3M | 0.98% | 1,949,500 | Common | SHARED |
| 30303M102 | META | META PLATFORMS INC | $19.2M | 0.97% | 26,008 | Common | SHARED |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $19.1M | 0.97% | 1,050,000 | Common | SHARED |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $18.9M | 0.96% | 1,418,984 | Common | SHARED |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $18.9M | 0.95% | 150,000 | Common | SHARED |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $18.6M | 0.94% | 2,097,500 | Common | SHARED |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $17.6M | 0.89% | 4,889,200 | Common | SHARED |
| 37733W204 | GSK | GSK PLC | $15.4M | 0.78% | 400,000 | Common | SHARED |
| 23256X407 | HELP | CYBIN INC | $15.4M | 0.78% | 1,830,097 | Common | SHARED |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $14.3M | 0.72% | 1,143,759 | Common | SHARED |
| 98985Y108 | ZYME | ZYMEWORKS INC | $13.8M | 0.70% | 1,100,000 | Common | SHARED |
| M96088105 | URGN | UROGEN PHARMA LTD | $13.7M | 0.69% | 1,000,000 | Common | SHARED |
| 48115J109 | DERM | JOURNEY MED CORP | $13.3M | 0.67% | 1,854,596 | Common | SHARED |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $12.6M | 0.64% | 3,059,630 | Common | SHARED |
| 87918A105 | TDOC | TELADOC HEALTH INC | $12.2M | 0.62% | 1,400,000 | Common | SHARED |
| 65487U108 | NKTX | NKARTA INC | $11.7M | 0.59% | 7,055,576 | Common | SHARED |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $11.4M | 0.58% | 800,100 | Common | SHARED |
| 921659108 | VNDA | VANDA PHARMACEUTICALS INC | $11.1M | 0.56% | 2,353,307 | Common | SHARED |
| 02155H200 | ALT | ALTIMMUNE INC | $10.6M | 0.54% | 2,750,000 | Common | SHARED |
| 046353108 | AZNN | ASTRAZENECA PLC | $10.5M | 0.53% | 150,000 | Common | SHARED |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $10.4M | 0.52% | 700,000 | Common | SHARED |
| 04335A105 | ARVN | ARVINAS INC | $10.3M | 0.52% | 1,393,800 | Common | SHARED |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $9.8M | 0.50% | 370,000 | Common | SHARED |
| 43157M102 | — | HILLEVAX INC | $9.8M | 0.49% | 4,920,000 | Common | SHARED |
| 92243G108 | PCVX | VAXCYTE INC | $9.8M | 0.49% | 300,000 | Common | SHARED |
| 80105N105 | SNY | SANOFI | $9.7M | 0.49% | 200,000 | Common | SHARED |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $9.2M | 0.47% | 100,000 | Common | SHARED |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $8.9M | 0.45% | 2,600,000 | Common | SHARED |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $8.9M | 0.45% | 281,200 | Common | SHARED |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $8.7M | 0.44% | 200,000 | Common | SHARED |
| 45168D104 | IDXX | IDEXX LABS INC | $8.6M | 0.43% | 16,000 | Common | SHARED |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $8.4M | 0.43% | 1,121,138 | Common | SHARED |
| 60770K107 | MRNA | MODERNA INC | $8.4M | 0.43% | 305,300 | Common | SHARED |
| 01609W102 | BABA | ALIBABA GROUP HOLDING LTD ADR | $7.9M | 0.40% | 70,000 | Common | SHARED |
| 532457108 | LLY | ELI LILLY & CO | $7.8M | 0.39% | 10,000 | Common | SHARED |
| 67080N101 | NUVB | NUVATION BIO INC | $7.6M | 0.38% | 3,900,000 | Common | SHARED |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $7.3M | 0.37% | 4,300,000 | Common | SHARED |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $7.2M | 0.36% | 420,300 | Common | SHARED |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $7.2M | 0.36% | 800,000 | Common | SHARED |
| 071705107 | BLCO | BAUSCH PLUS LOMB CORP | $7.2M | 0.36% | 550,000 | Common | SHARED |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $7.0M | 0.35% | 6,000,000 | Common | SHARED |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $6.6M | 0.34% | 3,100,000 | Common | SHARED |
| 09077V100 | BIOA | BIOAGE LABS INC | $6.6M | 0.33% | 1,600,000 | Common | SHARED |
| 45256X103 | IBRX | IMMUNITYBIO INC | $6.2M | 0.31% | 2,333,333 | Common | SHARED |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $6.0M | 0.30% | 1,780,975 | Common | SHARED |
| 022307102 | ALMS | ALUMIS INC | $6.0M | 0.30% | 1,996,797 | Common | SHARED |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $5.9M | 0.30% | 150,000 | Common | SHARED |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $5.7M | 0.29% | 500,000 | Common | SHARED |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $5.7M | 0.29% | 431,300 | Common | SHARED |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $5.3M | 0.27% | 250,000 | Common | SHARED |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $5.3M | 0.27% | 10,000 | Common | SHARED |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $5.1M | 0.26% | 2,070,209 | Common | SHARED |
| 88427A107 | — | THIRD HARMONIC BIO INC | $5.0M | 0.26% | 929,727 | Common | SHARED |
| 007002108 | TORCEUR | ADICET BIO INC | $5.0M | 0.25% | 8,223,612 | Common | SHARED |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $4.9M | 0.25% | 264,692 | Common | SHARED |
| 071734107 | BHC | BAUSCH HEALTH COS INC | $4.9M | 0.25% | 736,827 | Common | SHARED |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $4.6M | 0.23% | 200,000 | Common | SHARED |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $4.5M | 0.23% | 10,000 | Common | SHARED |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $4.4M | 0.22% | 2,135,459 | Common | SHARED |
| 09062X103 | BIIB | BIOGEN INC | $4.4M | 0.22% | 35,000 | Common | SHARED |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $4.2M | 0.21% | 50,000 | Common | SHARED |
| 372303206 | GMAB | GENMAB A/S | $4.1M | 0.21% | 200,000 | Common | SHARED |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $4.1M | 0.21% | 50,000 | Common | SHARED |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $3.9M | 0.20% | 600,200 | Common | SHARED |
| 670703107 | NUVL | NUVALENT INC | $3.8M | 0.19% | 50,000 | Common | SHARED |
| 670002401 | NVAX | NOVAVAX INC | $3.8M | 0.19% | 600,000 | Common | SHARED |
| 19249H103 | CHRS | COHERUS ONCOLOGY INC | $3.7M | 0.19% | 5,097,362 | Common | SHARED |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $3.7M | 0.19% | 100,000 | Common | SHARED |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $3.6M | 0.18% | 1,300,000 | Common | SHARED |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $3.6M | 0.18% | 100,000 | Common | SHARED |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $3.6M | 0.18% | 179,166 | Common | SHARED |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $3.5M | 0.18% | 74,265 | Common | SHARED |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $3.5M | 0.18% | 205,000 | Common | SHARED |
| 002120202 | ATYR | ATYR PHARMA INC | $3.4M | 0.17% | 671,134 | Common | SHARED |
| 23282W605 | CYTK | CYTOKINETICS INC | $3.3M | 0.17% | 100,000 | Common | SHARED |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $3.3M | 0.17% | 720,000 | Common | SHARED |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $3.1M | 0.16% | 1,800,000 | Common | SHARED |
| G8807B106 | TBPH | THERAVANCE BIOPHARMA INC | $2.9M | 0.15% | 264,308 | Common | SHARED |
| 015271109 | ARE | ALEXANDRIA REAL ESTATE EQ IN | $2.9M | 0.15% | 40,000 | Common | SHARED |
| 81578P106 | SEER | SEER INC | $2.9M | 0.15% | 1,344,423 | Common | SHARED |
| 59267L107 | — | METSERA INC | $2.8M | 0.14% | 100,000 | Common | SHARED |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $2.8M | 0.14% | 2,500,000 | Common | SHARED |
| 74019P207 | DTIL | PRECISION BIOSCIENCES INC | $2.7M | 0.14% | 653,649 | Common | SHARED |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $2.7M | 0.14% | 200,000 | Common | SHARED |
| 156944100 | CGON | CG ONCOLOGY INC | $2.3M | 0.11% | 87,500 | Common | SHARED |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $2.1M | 0.11% | 1,867,773 | Common | SHARED |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $2.1M | 0.11% | 850,000 | Common | SHARED |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $2.1M | 0.11% | 900,000 | Common | SHARED |
| G1110E107 | BHVN | BIOHAVEN LTD | $2.0M | 0.10% | 140,000 | Common | SHARED |
| 14167L103 | CDNA | CAREDX INC | $2.0M | 0.10% | 100,000 | Common | SHARED |
| 29479A108 | ERAS | ERASCA INC | $1.9M | 0.10% | 1,502,915 | Common | SHARED |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $1.9M | 0.09% | 200,000 | Common | SHARED |
| 46625H100 | JPM | JPMORGAN CHASE & CO. | $1.8M | 0.09% | 6,312 | Common | SHARED |
| 869367102 | STRO | SUTRO BIOPHARMA INC | $1.8M | 0.09% | 2,561,586 | Common | SHARED |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $1.8M | 0.09% | 1,550,000 | Common | SHARED |
| 254687106 | DIS | DISNEY WALT CO | $1.8M | 0.09% | 14,493 | Common | SHARED |
| 594918104 | MSFT | MICROSOFT CORP | $1.8M | 0.09% | 3,546 | Common | SHARED |
| 92826C839 | V | VISA INC | $1.7M | 0.09% | 4,869 | Common | SHARED |
| 931142103 | WMT | WALMART INC | $1.7M | 0.09% | 17,242 | Common | SHARED |
| 191216100 | KO | COCA COLA CO | $1.6M | 0.08% | 22,712 | Common | SHARED |
| 084670702 | BRK/B | BERKSHIRE HATHAWAY INC DEL | $1.6M | 0.08% | 3,250 | Common | SHARED |
| 92343V104 | VZ | VERIZON COMMUNICATIONS INC | $1.6M | 0.08% | 36,266 | Common | SHARED |
| 882508104 | TXN | TEXAS INSTRS INC | $1.5M | 0.08% | 7,415 | Common | SHARED |
| 458140100 | INTC | INTEL CORP | $1.5M | 0.07% | 66,216 | Common | SHARED |
| 64110L106 | NFLX | NETFLIX INC | $1.5M | 0.07% | 1,089 | Common | SHARED |
| 478160104 | JNJ | JOHNSON & JOHNSON | $1.4M | 0.07% | 9,472 | Common | SHARED |
| 742718109 | PG | PROCTER AND GAMBLE CO | $1.4M | 0.07% | 8,952 | Common | SHARED |
| 654106103 | NKE | NIKE INC | $1.4M | 0.07% | 19,399 | Common | SHARED |
| 30231G102 | XOM | EXXON MOBIL CORP | $1.4M | 0.07% | 12,651 | Common | SHARED |
| 68401U204 | OPRX | OPTIMIZERX CORP | $1.4M | 0.07% | 100,000 | Common | SHARED |
| 437076102 | HD | HOME DEPOT INC | $1.3M | 0.07% | 3,646 | Common | SHARED |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $1.3M | 0.07% | 3,158,265 | Common | SHARED |
| 70450Y103 | PYPL | PAYPAL HLDGS INC | $1.3M | 0.07% | 17,323 | Common | SHARED |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $1.3M | 0.07% | 900,000 | Common | SHARED |
| 717081103 | PFE | PFIZER INC | $1.3M | 0.06% | 53,039 | Common | SHARED |
| 369604301 | GE | GE AEROSPACE | $1.3M | 0.06% | 4,986 | Common | SHARED |
| 36828A101 | GEV | GE VERNOVA INC | $1.3M | 0.06% | 2,421 | Common | SHARED |
| 28658R106 | CLYM | CLIMB BIO INC | $1.2M | 0.06% | 1,000,000 | Common | SHARED |
| 92556V106 | VTRS | VIATRIS INC | $1.1M | 0.06% | 128,359 | Common | SHARED |
| 90384S303 | ULTA | ULTA BEAUTY INC | $1.1M | 0.06% | 2,410 | Common | SHARED |
| 92337C203 | VSTM | VERASTEM INC | $1.1M | 0.06% | 270,000 | Common | SHARED |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC | $1.0M | 0.05% | 1,400,000 | Common | SHARED |
| 01626L204 | ALGS | ALIGOS THERAPEUTICS INC | $1.0M | 0.05% | 141,131 | Common | SHARED |
| 025816109 | AXP | AMERICAN EXPRESS CO | $1.0M | 0.05% | 3,168 | Common | SHARED |
| 024013104 | AAT | AMERICAN ASSETS TR INC | $987,500 | 0.05% | 50,000 | Common | SHARED |
| 482929106 | KLRS | KALARIS THERAPEUTICS, INC | $963,493 | 0.05% | 360,859 | Common | SHARED |
| 097702203 | BOLT | BOLT BIOTHERAPEUTICS INC | $962,892 | 0.05% | 166,879 | Common | SHARED |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $957,512 | 0.05% | 126,655 | Common | SHARED |
| 023135106 | AMZN | AMAZON COM INC | $946,526 | 0.05% | 4,314 | Common | SHARED |
| 87978U207 | TPST | TEMPEST THERAPEUTICS INC | $944,942 | 0.05% | 138,962 | Common | SHARED |
| 872590104 | TMUS | T-MOBILE US INC | $904,443 | 0.05% | 3,796 | Common | SHARED |
| 020002101 | ALL | ALLSTATE CORP | $903,451 | 0.05% | 4,488 | Common | SHARED |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $879,888 | 0.04% | 127,520 | Common | SHARED |
| 704326107 | PAYX | PAYCHEX INC | $879,718 | 0.04% | 6,048 | Common | SHARED |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $870,000 | 0.04% | 600,000 | Common | SHARED |
| 580135101 | MCD | MCDONALDS CORP | $854,459 | 0.04% | 2,925 | Common | SHARED |
| 440452100 | HRL | HORMEL FOODS CORP | $849,852 | 0.04% | 28,094 | Common | SHARED |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $848,824 | 0.04% | 2,721 | Common | SHARED |
| 42824C109 | HPE | HEWLETT PACKARD ENTERPRISE C | $818,032 | 0.04% | 40,002 | Common | SHARED |
| 345370860 | F | FORD MTR CO | $817,869 | 0.04% | 75,380 | Common | SHARED |
| G2545C104 | CBIO | CRESCENT BIOPHARMA INC. | $809,453 | 0.04% | 50,152 | Common | SHARED |
| 824348106 | SHW | SHERWIN WILLIAMS CO | $804,518 | 0.04% | 2,343 | Common | SHARED |
| 910047109 | UAL | UNITED AIRLS HLDGS INC | $801,471 | 0.04% | 10,065 | Common | SHARED |
| 963320106 | WHR | WHIRLPOOL CORP | $766,006 | 0.04% | 7,553 | Common | SHARED |
| 81211K100 | SDA | SEALED AIR CORP NEW | $757,140 | 0.04% | 24,400 | Common | SHARED |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $755,403 | 0.04% | 2,428,169 | Common | SHARED |
| 166764100 | CVX | CHEVRON CORP NEW | $750,195 | 0.04% | 5,239 | Common | SHARED |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $686,000 | 0.03% | 200,000 | Common | SHARED |
| 31428X106 | FDX | FEDEX CORP | $657,468 | 0.03% | 2,892 | Common | SHARED |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $657,000 | 0.03% | 50,000 | Common | SHARED |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $641,000 | 0.03% | 100,000 | Common | SHARED |
| 189054109 | CLX | CLOROX CO DEL | $618,810 | 0.03% | 5,154 | Common | SHARED |
| 702712100 | PASG | PASSAGE BIO INC | $600,450 | 0.03% | 1,500,000 | Common | SHARED |
| 50127T109 | KURA | KURA ONCOLOGY INC | $577,000 | 0.03% | 100,000 | Common | SHARED |
| 09077B104 | BCABGBP | BIOATLA INC | $544,134 | 0.03% | 1,374,076 | Common | SHARED |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $536,000 | 0.03% | 100,000 | Common | SHARED |
| 68218J103 | OABI | OMNIAB INC | $522,000 | 0.03% | 300,000 | Common | SHARED |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $502,830 | 0.03% | 900,000 | Common | SHARED |
| 34965K107 | FTRE | FORTREA HLDGS INC | $494,000 | 0.02% | 100,000 | Common | SHARED |
| 34385P108 | LAB | STANDARD BIOTOOLS INC | $489,306 | 0.02% | 407,755 | Common | SHARED |
| 14817C107 | FLNA | CASSAVA SCIENCES INC COMMON STOCK | $434,074 | 0.02% | 239,820 | Common | SHARED |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $404,496 | 0.02% | 169,245 | Common | SHARED |
| 50015M109 | KOD | KODIAK SCIENCES INC | $373,000 | 0.02% | 100,000 | Common | SHARED |
| 59102M104 | MGX | METAGENOMI INC | $296,000 | 0.01% | 200,000 | Common | SHARED |
| 00534A102 | IVVD | INVIVYD INC | $286,000 | 0.01% | 400,000 | Common | SHARED |
| 556099109 | MGNX | MACROGENICS INC | $264,816 | 0.01% | 218,856 | Common | SHARED |
| 04746L104 | — | ATHIRA PHARMA INC | $181,200 | 0.01% | 600,000 | Common | SHARED |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $170,374 | 0.01% | 20,527 | Common | SHARED |
| 81750R201 | MCRB | SERES THERAPEUTICS INC | $154,662 | 0.01% | 13,921 | Common | SHARED |
| 005083100 | ACTU | ACTUATE THERAPEUTICS INC | $32,035 | 0.00% | 5,243 | Common | SHARED |
| 363225202 | GALT | GALECTIN THERAPEUTICS INC | $27,246 | 0.00% | 12,913 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.